Study of FXB0871 for Advanced Solid Tumors
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This is an early-stage trial testing a new drug called FXB0871 to treat advanced cancers that have spread or haven't responded to standard treatments. The drug works by helping your immune system fight cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have advanced or metastatic solid tumor (cancer that has spread) confirmed by biopsy
- Your cancer has progressed despite standard treatment, or you cannot tolerate standard options
- You are in good enough overall health (ECOG score 0–1: able to do light activities)
- Your heart and lung function meet safety requirements, including oxygen levels above 92% and ejection fraction above 50%
- You have tumor tissue available for testing (from previous biopsy or new biopsy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called XB371 for people with advanced solid tumors that have come back or spread. It aims to see if the drug is safe and works against the cancer.
This trial tests an investigational drug called FTL008.16 for people with advanced solid tumors that may carry a protein called 5T4. The main goal is to see if the drug is safe and tolerable.
This trial tests a new drug, FXS887, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how it affects the tumors.
This Phase 1 trial tests HS-20089 in people with advanced solid cancers that have limited standard treatment options. It focuses on safety and early signs of whether the drug can shrink tumors or control them.
This trial tests a new drug called FH-006 for people with advanced solid tumors that cannot be surgically removed or have spread. It aims to see if the drug is safe and effective.
This trial tests a new drug called FG-B901, either by itself or combined with chemotherapy, in people with advanced cancer that has spread or didn't respond to standard treatments. The goal is to see if it can shrink tumors and help patients live longer.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.